Tag Archives: treatment

Injectafer (ferric carboxymaltose injection) Receives FDA Approval for Single Dose Option for the Treatment of Adult Patients with Iron Deficiency Anemia

BASKING RIDGE, N.J. and SHIRLEY, N.Y., May 6, 2021 /PRNewswire/ — Daiichi Sankyo, Inc. and American Regent, Inc., a Daiichi Sankyo Group company, today announced that the U.S. Food and Drug Administration (FDA) has approved a single 1000 mg dose option of Injectafer® (ferric carboxymaltose injection), an iron replacement product, for the treatment of iron deficiency anemia (IDA) in adult… Read More: Injectafer (ferric carboxymaltose injection) Receives FDA Approval for Single Dose… »

MDMA Reaches Next Step Toward Approval for Treatment

Scott Ostrom, a participant in the trial, has suffered from P.T.S.D. since returning from Iraq in 2007. Now, he no longer has nightmares. “Literally, I’m a different person,” he said.Credit…Elliot Ross for The New York Times SectionsSkip to contentSkip to site index A Psychedelic Drug Passes a Big Test for PTSD Treatment A new study… Read More: MDMA Reaches Next Step Toward Approval for Treatment »

Is There Treatment for Varicose Veins?

What Are Varicose Veins, and What Causes Them? Blood is meant to travel from your heart throughout your body via your veins. These veins have valves that open to let blood flow past and close off behind it. When these valves aren’t working correctly or become weak, blood is then backed up around the vein… Read More: Is There Treatment for Varicose Veins? »

FDA Approves Qelbree (viloxazine) for the Treatment of ADHD

FDA Approves Qelbree (viloxazine) for the Treatment of ADHD ROCKVILLE, Md., April 02, 2021 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that the U.S. Food and Drug Administration (FDA) approved Qelbree (viloxazine extended-release capsules) for the treatment of attention-deficit hyperactivity… Read More: FDA Approves Qelbree (viloxazine) for the Treatment of ADHD »